We are live on ! Find out more
SLG

Stanley-Laman Group Portfolio holdings

AUM $814M
1-Year Est. Return 40.24%
This Fund
S&P 500
This Quarter Est. Return
+3.23%
1 Year Est. Return
+40.24%
3 Year Est. Return
+82.87%
5 Year Est. Return
+77.64%
10 Year Est. Return
+275.61%
AUM
$463M
AUM Growth
+$88.4M
Cap. Flow
+$76.3M
Cap. Flow %
16.48%
Top 10 Hldgs %
15.82%
Holding
310
New
106
Increased
69
Reduced
87
Closed
41

Top Buys

Rank Stock Value
1
PFPT
Proofpoint, Inc.
PFPT
+$5.74M
2
LJPC
La Jolla Pharmaceutical Company
LJPC
+$5.51M
3
ACAD icon
Acadia Pharmaceuticals
ACAD
+$5.03M
4
IMPV
Imperva, Inc.
IMPV
+$4.56M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$2.3M

Top Sells

Rank Stock Value
1
TEN
Tenneco Inc. Class A Voting Common Stock
TEN
+$4.9M
2
TSCO icon
Tractor Supply
TSCO
+$4.44M
3
LPNT
LifePoint Health, Inc.
LPNT
+$3.96M
4
WCC
WESCO International
WCC
+$3.55M
5
IDTI
Integrated Device Technology I
IDTI
+$3.36M

Sector Composition

Rank Sector Weight
1 Healthcare 15.33%
2 Technology 14.58%
3 Industrials 10.71%
4 Consumer Staples 7.92%
5 Materials 7.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VCIT icon
176
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.1B
$390K 0.08%
4,467
-1,042
-19% -$91.3K
MSFT icon
177
Microsoft
MSFT
$2.84T
$348K 0.08%
4,065
-356
-8% -$29.2K
KWR icon
178
Quaker Houghton
KWR
$2.63B
$332K 0.07%
2,200
-200
-8% -$30.9K
SHV icon
179
iShares 0-1 Year Treasury Bond ETF
SHV
$20.7B
$330K 0.07%
2,995
-614
-17% -$67.7K
CVX icon
180
Chevron
CVX
$388B
$291K 0.06%
2,328
-300
-11% -$35.6K
XOM icon
181
ExxonMobil
XOM
$651B
$265K 0.06%
3,172
-200
-6% -$16.5K
COP icon
182
ConocoPhillips
COP
$147B
$247K 0.05%
4,498
-150
-3% -$7.71K
AMZN icon
183
Amazon
AMZN
$2.5T
$242K 0.05%
+4,140
New +$228K
MFC icon
184
Manulife Financial
MFC
$72.6B
$241K 0.05%
11,542
– –
PPL
185
PPL Corp
PPL
$27.3B
$215K 0.05%
6,954
– –
BABA icon
186
Alibaba
BABA
$269B
$210K 0.05%
+1,215
New +$218K
BIP icon
187
Brookfield Infrastructure Partners
BIP
$18.8B
$202K 0.04%
+7,560
New +$196K
NBRV
188
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$154K 0.03%
+103
New +$163K
FLG
189
Flagstar Bank National Association
FLG
$5.77B
$138K 0.03%
3,533
– –
TOVX icon
190
Theriva Biologics
TOVX
$10.2M
$31K 0.01%
7
– –
NBSE
191
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$22K ﹤0.01%
+30
New +$11.6K
AMAT icon
192
Applied Materials
AMAT
$426B
– –
-14,570
Closed -$759K
AMWD
193
DELISTED
American Woodmark
AMWD
– –
-6,701
Closed -$645K
BNS icon
194
Scotiabank
BNS
$106B
– –
-10,072
Closed -$647K
BR icon
195
Broadridge
BR
$17.2B
– –
-9,988
Closed -$807K
CAH icon
196
Cardinal Health
CAH
$53.4B
– –
-7,799
Closed -$522K
CL icon
197
Colgate-Palmolive
CL
$72.6B
– –
-2,839
Closed -$207K
DDS icon
198
Dillards
DDS
$8.87B
– –
-9,311
Closed -$522K
DMF
199
DELISTED
BNY Mellon Municipal Income
DMF
– –
-10,372
Closed -$95K
ELV icon
200
Elevance Health
ELV
$81.9B
– –
-3,726
Closed -$707K
6 7
8
9 10

Similar funds

VFG
Victory Financial Group Austin, Texas $814M AUM 18.17% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
CICI
Capital Investment Counsel Inc Raleigh, North Carolina $816M AUM 34.73% 1-Year Est. Return
UAG
United Advisor Group Cincinnati, Ohio $811M AUM 18.32% 1-Year Est. Return
PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
BC
Brio Consultants San Francisco, California $818M AUM 13.48% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return

Stanley-Laman Group's Q4 2017 Portfolio in Review

As of Q4 2017, Stanley-Laman Group held 310 positions worth $463M, up 24% from $375M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Stanley-Laman Group deployed $76.3M of net new capital in Q4 2017, opening 106 new positions and adding to 69 existing holdings. Its largest new stake was La Jolla Pharmaceutical Company: 168,653 shares worth $5.43M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 18% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was JBT Marel, an estimated $889K trimmed.

  • Stanley-Laman Group's largest Q4 2017 buy was La Jolla Pharmaceutical Company: 168,653 shares worth $5.43M.
  • Stanley-Laman Group added most to Proofpoint, Inc. in Q4 2017, an estimated $5.74M increase.
  • Stanley-Laman Group's biggest Q4 2017 reduction was JBT Marel, cutting an estimated $889K.
  • Stanley-Laman Group fully exited Tenneco Inc. Class A Voting Common Stock in Q4 2017, selling an estimated $4.9M.
  • Stanley-Laman Group's ten largest holdings make up 16% of its $463M portfolio in Q4 2017.
  • Stanley-Laman Group opened 106 new positions and closed 41 in Q4 2017.
  • Stanley-Laman Group's portfolio value rose 24% quarter-over-quarter to $463M.

Based on Stanley-Laman Group's 13F filing for Q4 2017, filed 9 Feb 2018.